To identify whichPDE inhibitors were able to attenuate the proliferation of U87MG, A172 and T98G glioblastoma cells, we tested 28 compounds inhibiting all the major PDE classes, using the CCK-8 viability assay (Figure 1). Here, ALDH7A1 is linked to glioblastoma.